MATK Martek Biosciences Corporation featured news, full reports, and detailed charts
Martek Biosciences Corporation (MATK) Wrap Up:
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life’sDHA™, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in infant formula, perinatal products, foods and beverages and dietary supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. NUTRITIONAL PRODUCTS We have developed production methods and intellectual property for two important fatty acids. These fatty acids are DHA and ARA. We sell oils containing these fatty acids under the names DHASCO®, life’sDHA™, Neuromins® and ARASCO®. We derive DHA from microalgae and ARA from fungi, using proprietary processes. Cell membranes throughout the body contain these fatty acids, and they are particularly concentrated in the brain, central nervous system, retina and heart. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2007%2f01%2f16%2f0000950133-07-000126.html#FIS_BUSINESS"Martek Biosciences Corp. (MATK:NASDAQ)
Snapshot of Martek Biosciences Corp. (MATK)
|
OPEN
$17.63
|
PREVIOUS CLOSE
$17.77
|
|
|
DAY HIGH
$17.69
|
DAY LOW
$17.15
|
|
|
52 WEEK HIGH
01/5/09 - $31.35
|
52 WEEK LOW
03/9/09 - $15.36
|
|
|
MARKET CAP
577.4M
|
AVERAGE VOLUME 3 mo
292.1K
|
|
|
DILUTED EPS TTM
$1.20
|
SHARES OUTSTANDING
33.2M
|
|
|
MATK Does Not Pay Dividends
|
P/E TTM
14.5x
|
|
| K = Thousands M = Millions B = Billions | ||
MATK Top Compensated Officers
Executives, Board Directors
Key developments for Martek Biosciences Corp. (MATK)
Martek Biosciences Corp. announced that life'sDHA is featured in the new Nutrioli DHA cooking oil. This is the first product launch from Ragasa to feature Martek's life'sDHA, and the first Mexican cooking oil to feature DHA for brain health. The life'sDHA logo will be prominently displayed on all Nutrioli DHA packaging and in all marketing efforts, which will include broadcast, print and web advertising.
Martek Biosciences Corp. announced the election of David M. Pernock to its Board of Directors. Mr. Pernock brings to Martek's Board an extensive background in the commercialization of pharmaceutical products, having served from 1994 to 2009 in a variety of executive capacities for GlaxoSmithKline (GSK), one of the healthcare companies. In his most recent executive role, Mr. Pernock served as Senior Vice President in charge of GSK's pharmaceutical, vaccines, oncology, acute care and HIV divisions in the United States.
Martek Biosciences Corp. - Conference Presentation Calls
MATK Competitors
| Company | Last | Change |
| Archer Daniels Midland Co | $31.57 USD | -0.35 |
| Mera Pharmaceuticals Inc | $0.0045 USD | -0.0015 |
| Nagase and Co Ltd | ¥1,028 JPY | -22.00 |
| Koninklijke DSM | €32.62 EUR | -0.405 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | MATK | Industry Range |
| Price/Earnings | 14.8x |
|
| Price/Sales | 1.7x |
|
| Price/Book | 0.9x |
|
| Price/Cash Flow | 12.6x |
|
| TEV/Sales | 1.3x |
|
|
MATK |
||
MATK transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||